Cargando…
Changes in lactate dehydrogenase on admission throughout the COVID-19 pandemic and possible impacts on prognostic capability
Introduction: The enzyme lactate dehydrogenase (LDH) is a good marker of general hyperinflammation correlated with mortality for COVID-19, and is therefore used in prognosis tools. In a current COVID-19 clinical randomized trial (CRT), the blood level of LDH was selected as an inclusion criterion. H...
Autores principales: | Medina-Hernández, Elba O, Pérez-Navarro, Lucía M, Hernández-Ruiz, Joselín, Villalobos-Osnaya, Alma, L Hernández-Medel, María, Casillas-Suárez, Catalina, Pérez-García, Adolfo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9443787/ https://www.ncbi.nlm.nih.gov/pubmed/36052694 http://dx.doi.org/10.2217/bmm-2022-0364 |
Ejemplares similares
-
Blocking EGFR with nimotuzumab: a novel strategy for COVID-19 treatment
por: Londres, Henrry Diaz, et al.
Publicado: (2022) -
The first direct synthesis of β-unsubstituted meso-decamethylcalix[5]pyrrole
por: Chacón-García, Luis, et al.
Publicado: (2009) -
Ozone therapy for patients with COVID-19 pneumonia: Preliminary report of a prospective case-control study
por: Hernández, Alberto, et al.
Publicado: (2021) -
Conducting polymer-based multilayer films for instructive biomaterial coatings
por: Hardy, John G, et al.
Publicado: (2015) -
Flocculation and Expression of FLO Genes of a Saccharomyces cerevisiae Mezcal Strain with High Stress Tolerance
por: Vergara-Álvarez, Israel, et al.
Publicado: (2019)